Cefazolin and Ferrous fumarate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Ferrous fumarate (ferrous fumarate). Common drug interactions include clostridium test positive among females and clostridium test positive among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Ferrous fumarate. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Ferrous fumarate?

Ferrous fumarate has active ingredients of ferrous fumarate. It is often used in anemia. eHealthMe is studying from 9,840 Ferrous fumarate users. Check the latest studies of Ferrous fumarate.

On Jul, 11, 2026

25 people who take Cefazolin and Ferrous fumarate together, and have interactions are studied.

Cefazolin and Ferrous fumarate drug interactions.

What are the common drug interactions of Cefazolin and Ferrous Fumarate, by gender? *:

female:

Clostridium test positive
Depressed level of consciousness
Dyspnoea (difficult or laboured respiration)
Lethargy (tiredness)
Unresponsive to stimuli
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood bilirubin increased
Blood lactate dehydrogenase increased
Catheter site pain

male:

Clostridium test positive
Intestinal perforation (complete penetration of the wall of the intestine)
Somnolence (a state of near-sleep, a strong desire for sleep)
Arthralgia (joint pain)
Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Cholestatic liver injury (due to injury bile cannot floe from liver)
Death
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Dysphagia (a condition in which swallowing is difficult or painful)
Endocrine ophthalmopathy (increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism)

What are the common drug interactions of Cefazolin and Ferrous Fumarate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Catheter site pain
Device occlusion
Liver disorder (liver diseases)

30-39:

Catheter site infection (infection at the site of insertion)
Cholecystitis acute (rapid infection of gallbladder)
Epistaxis (bleed from the nose)
Post procedural haemorrhage (post procedural bleeding)
Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Endocrine ophthalmopathy (increased water content of retroocular orbital tissues; associated with thyroid disease, usually hyperthyroidism)
Hyperthyroidism (over activity of the thyroid gland)

40-49:

Cellulitis (infection under the skin)

50-59:

Cholestatic liver injury (due to injury bile cannot floe from liver)

60+:

Clostridium test positive
Depressed level of consciousness
Arthralgia (joint pain)
Cellulitis (infection under the skin)
Death
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Dysphagia (a condition in which swallowing is difficult or painful)
Enlarged uvula
Gouty arthritis (joint inflammation with crystal formation)
Pyrexia (fever)

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 12.00%
Wound Infection: 2 people, 8.00%
Fever: 2 people, 8.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.00%
B-Cell Unclassifiable Lymphoma High Grade (rapidly progressing unclassifiable b-cell cancer difficult to treat- high grade): 2 people, 8.00%
Biliary Tract Infection: 2 people, 8.00%
Bone Marrow Conditioning Regimen: 2 people, 8.00%
Catheter Site Infection (infection at the site of insertion): 2 people, 8.00%
Cholecystitis Acute (rapid infection of gallbladder): 2 people, 8.00%
Diarrhea: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and Ferrous fumarate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously